SYNthesis BioVentures
Est. dry powder
$4M
Raised, not yet invested
AUM
$18.4M
Assets under management
Latest fund
$50M
SYNthesis BioVentures I
Est. cheque size
$499.6K–
From fund sizes
Deals, last 12 months
—
Not reported
About SYNthesis BioVentures
SYNthesis BioVentures is an early-stage firm that invests in therapeutics, pharmaceuticals, biologics, and cell & gene therapy companies across Australia.
- Type
- Venture Capital Firm
- Headquarters
- Melbourne, Victoria, Australia
- Stages
- SeedEarly Stage
- Est. cheque size
- $499.6K–$2.5M
- Sectors
- Healthcare
- Regions
- Australasia
- Strategies
- Pre-Seed, Seed, Series A
Where they invest
From deals and portfolio companies on record
Most frequent rounds
Not enough data
Across 1 deals
Portfolio sectors
- Biotechnology1
Across 1 companies
Portfolio countries
- Australia1
Across 1 companies
Recent investments
Newest 1 of 1
- Unspecified Round$7.8M
Catalyst Therapeutics Pty Ltd.
May 2023 · Unspecified Round
Offices
1 location
- Melbourne, Victoria, AustraliaHQ
Questions about SYNthesis BioVentures
How much does SYNthesis BioVentures invest per deal?
Based on the size of its funds, SYNthesis BioVentures writes estimated cheques of $499.6K–$2.5M. Lead cheques usually sit at the top of that range and follow-on cheques lower.
What stages does SYNthesis BioVentures invest in?
SYNthesis BioVentures has invested at Seed and Early Stage.
How much capital does SYNthesis BioVentures have left to invest?
SYNthesis BioVentures has an estimated $4M in dry powder: capital it has raised but not yet invested.